What are the findings of the quinquennial review of the Medical Devices Agency, which was announced on 2 May; and what is the future status of the Medical Devices Agency and the Medicines Control Agency. [HL 3873]. - Inc announcement publishing report today.

What are the findings of the quinquennial review of the Medical Devices Agency, which was announced on 2 May; and what is the future status of the Medical Devices Agency and the Medicines Control Agency. [HL 3873]. - Inc announcement publishing report today.

What is the outcome of their consideration of the public response to the Medicines Control Agencys proposals for classifying borderline products, as published in its consultation letter MLX 249. [HL 3715].

What is the outcome of their consideration of the public response to the Medicines Control Agencys proposals for classifying borderline products, as published in its consultation letter MLX 249. [HL 3715].

When they intend to publish the Annual Report and Accounts of the Medicines Control Agency. [HL 3719].

When they intend to publish the Annual Report and Accounts of the Medicines Control Agency. [HL 3719].

Statement on what is the future of the Medicines Control Agency. [HL 3185]. - Inc announcement that report of the Quinquennial Review of the Medicines Control Agency, copy in Library, and Chief Executive Dr Keith Jones remains for further 3 years.

Statement on what is the future of the Medicines Control Agency. [HL 3185]. - Inc announcement that report of the Quinquennial Review of the Medicines Control Agency, copy in Library, and Chief Executive Dr Keith Jones remains for further 3 years.

What legal advice they have received in connection with the legality under the Human Rights Act 1998 and the European Convention on Human Rights of the new procedures to be adopted by the Medicines Control Agency under the provisions of the Medicines (Advertising and Monitoring of Advertising) Amendment Regulations 1999...

What legal advice they have received in connection with the legality under the Human Rights Act 1998 and the European Convention on Human Rights of the new procedures to be adopted by the Medicines Control Agency under the provisions of the Medicines (Advertising and Monitoring of Advertising) Amendment Regulations 1999...

Further to the Answer by the Lord Hunt of Kings Heath on 11 May (HL Deb. c1089), whether they or the Medicines Control Agency have consulted with (a) Consumers of Health Choice, (b) The National Association of Health Stores or (c) The Health Food Manufacturers' Association about membership of the...

Further to the Answer by the Lord Hunt of Kings Heath on 11 May (HL Deb. c1089), whether they or the Medicines Control Agency have consulted with (a) Consumers of Health Choice, (b) The National Association of Health Stores or (c) The Health Food Manufacturers' Association about membership of the...

In the light of the comment of Lord Hunt of Kings Heath on 11 May that 'we are consulting with industry, professional and consumer interests on the nomination of suitably qualified people' (HL Deb. c1089), to serve on the independent review panel, why in the review decisions on advertisements to...

In the light of the comment of Lord Hunt of Kings Heath on 11 May that 'we are consulting with industry, professional and consumer interests on the nomination of suitably qualified people' (HL Deb. c1089), to serve on the independent review panel, why in the review decisions on advertisements to...

Lords debate on unstarred question on what steps the Department of Health are taking to preserve the public's access to a full range of safe dietary supplements.

Lords debate on unstarred question on what steps the Department of Health are taking to preserve the public's access to a full range of safe dietary supplements.

Why Consumers for Health Choice and the National Association of Health Stores were not included by the Medicines Control Agency in the circulation of the consultation letter dated 29 April about membership of the Independent Review Panel for Advertising of Medicines; why earlier commitments to involve these organisations in relevant...

Why Consumers for Health Choice and the National Association of Health Stores were not included by the Medicines Control Agency in the circulation of the consultation letter dated 29 April about membership of the Independent Review Panel for Advertising of Medicines; why earlier commitments to involve these organisations in relevant...

Whether they will identify the authors of the three letters that they have received supporting the proposals that they have received supporting the proposals outlined in the Medicines Control Agency consultation document, MLX249; and whether they will indicate what changes they intend to make to those proposals to take account...

Whether they will identify the authors of the three letters that they have received supporting the proposals that they have received supporting the proposals outlined in the Medicines Control Agency consultation document, MLX249; and whether they will indicate what changes they intend to make to those proposals to take account...

What is their policy for future action, and the timetable for any such action in relation to Medicines Control Agency consultation documents MLX 249 and MLX 239. [HL 2066].

What is their policy for future action, and the timetable for any such action in relation to Medicines Control Agency consultation documents MLX 249 and MLX 239. [HL 2066].

Statement on whether they will publish the high level targets for the Medicines Control Agency for 1999-2000. [HL 2107]. - Ref to annual business plan, in Library.

Statement on whether they will publish the high level targets for the Medicines Control Agency for 1999-2000. [HL 2107]. - Ref to annual business plan, in Library.

To which companies the Medicines Control Agency has written in the last 12 months notifying them that it is considering classifying as a medicine products which they currently market as a food, indicating in each case the ingredients concerned and (a) the scientific and (b) the legal basis for the...

To which companies the Medicines Control Agency has written in the last 12 months notifying them that it is considering classifying as a medicine products which they currently market as a food, indicating in each case the ingredients concerned and (a) the scientific and (b) the legal basis for the...

What are the main recommendations from the Better Regulation Task Force in relation to avoiding over-regulation; and whether they have applied those principles to the proposals published by the Medicines Control Agency in its Consultation Document MLX 249. [HL 1858].

What are the main recommendations from the Better Regulation Task Force in relation to avoiding over-regulation; and whether they have applied those principles to the proposals published by the Medicines Control Agency in its Consultation Document MLX 249. [HL 1858].

Whether they will consider amending SI 3144/1994 (which enforced EC Directive 65/65), concerning the Medicines Control Agency and the definition of a medicine, to take account of the views expressed by the National Association of Health Stores. [HL 1802].

Whether they will consider amending SI 3144/1994 (which enforced EC Directive 65/65), concerning the Medicines Control Agency and the definition of a medicine, to take account of the views expressed by the National Association of Health Stores. [HL 1802].

How many representations have been received from (a) Members of Parliament; and (b) others about the proposals set out in the Medicines Control Agency consultation document MLX 249; and how many of those representations (a) broadly supported and (b) broadly opposed the proposals in that document. [HL 1822].

How many representations have been received from (a) Members of Parliament; and (b) others about the proposals set out in the Medicines Control Agency consultation document MLX 249; and how many of those representations (a) broadly supported and (b) broadly opposed the proposals in that document. [HL 1822].

What was the outcome of the study into a possible merger between the Medicines Control Agency and the Medical Devices Agency. [HL 1916]. - Includes fact that report of the study placed in Library.

What was the outcome of the study into a possible merger between the Medicines Control Agency and the Medical Devices Agency. [HL 1916]. - Includes fact that report of the study placed in Library.

How many case reports from parents of adverse reaction by their children to vaccines the Medicines Control Agency has received; and further to the Written Answer by Baroness Hayman on 7 December, 595 c66WA, when they anticipate that the work of: (a) the Medicines Control Agency Working Group evaluating reports...

How many case reports from parents of adverse reaction by their children to vaccines the Medicines Control Agency has received; and further to the Written Answer by Baroness Hayman on 7 December, 595 c66WA, when they anticipate that the work of: (a) the Medicines Control Agency Working Group evaluating reports...

What plans they have for the future of the Medicines Control Agency and the Medical Devices Agency. [HL 243]. - Terms of reference in the Library.

What plans they have for the future of the Medicines Control Agency and the Medical Devices Agency. [HL 243]. - Terms of reference in the Library.